ÂÜÀòÂÒÂ×

Mobeen Faqih, PhD, MBA, is an experienced professional in the pharmaceutical industry, currently serving as Head of Cell Therapy ERM and Business Continuity at Bristol Myers Squibb since October 2011, where roles have included Director of Strategic Product Leadership and Development and Commercial Business Continuity Lead. Prior to this, Mobeen held positions at Sunovion, Wyeth, and Schering-Plough, focusing on solid dosage formulation, process engineering, and technology transfer. Mobeen holds an MBA in Finance, Strategy, and Leadership from NYU Stern School of Business, and a PhD and BS in Chemical Engineering from Rutgers University.